MarketCap
Aquestive Therapeutics AQST
$ 3.59
1.99%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
107 M |
Market Cap[1] |
$ 384 M |
EBITDA (LTM) |
$ -55.3 M |
P/E (LTM) |
-5.953846 |
P/S (LTM) |
8.4732 |
EPS (LTM) |
-0.65 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market |  Canada |
 |
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market | USA |
 |
Windtree Therapeutics
WINT
|
- | - | $ 26.8 M | Nasdaq Global Select Market | USA |
 |
Trean Insurance Group
TIG
|
- | - | $ 316 M | Nasdaq Global Select Market | USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | USA |
 |
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Annexon
ANNX
|
$ 4.2 | -0.36 % | $ 651 M | Nasdaq Global Select Market | USA |
 |
AbbVie
ABBV
|
$ 294.72 | 0.32 % | $ 521 B | NYSE,SPB | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market |  Israel |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.78 | 0.89 % | $ 296 M | Nasdaq Capital Market | USA |
 |
Axon Enterprise
AXON
|
$ 316.97 | 4.77 % | $ 24.7 B | Nasdaq Global Select Market,SPB | USA |
|
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 62.89 | 0.18 % | $ 128 B | NYSE,SPB | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market |  Britain |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
Cytokinetics, Incorporated
CYTK
|
$ 58.59 | 4.29 % | $ 7.04 M | Nasdaq Global Select Market,SPB | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 159.75 | 5.35 % | $ 20.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 467.97 | 0.59 % | $ 252 B | Nasdaq Global Select Market,SPB | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 248.31 | 1.17 % | $ 15.1 B | Nasdaq Global Select Market |  Irlanda |
 |
Johnson & Johnson
JNJ
|
$ 280.31 | -0.17 % | $ 675 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.17 | 0.64 % | $ 1.39 M | Nasdaq Global Select Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 1.49 | -1.97 % | $ 3.67 B | Nasdaq Capital Market | Israel |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.59 | -2.76 % | $ 2.62 M | NYSE American | Israel |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.13 | 8.17 % | $ 260 M | NYSE American | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
TCR2 Therapeutics
TCRR
|
- | - | $ 58.1 M | Nasdaq Global Select Market,SPB | USA |
 |
C4 Therapeutics
CCCC
|
$ 2.9 | -3.5 % | $ 240 M | Nasdaq Global Select Market | USA |
 |
Eli Lilly and Company
LLY
|
$ 1 437.4 | 0.36 % | $ 1.29 T | NYSE,SPB | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Compugen Ltd.
CGEN
|
$ 2.09 | -0.24 % | $ 195 M | Nasdaq Global Market,SPB | Israel |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.